# Belite Bio (stock symbol: BLTE) Logo in transparent PNG and SVG formats

## Belite Bio Logo large

### Belite Bio Logo large Download PNG (52.49 KB)

![Belite Bio Logo large Download PNG (52.49 KB)](/img/orig/BLTE_BIG-0ce3984b.png)

### Belite Bio Logo large Download SVG (8.27 KB)

![Belite Bio Logo large Download SVG (8.27 KB)](/img/orig/BLTE_BIG-b50a8226.svg)

## Belite Bio Logo icon format

### Belite Bio Logo icon format Download PNG (53.08 KB)

![Belite Bio Logo icon format Download PNG (53.08 KB)](/img/orig/BLTE-4ef66636.png)

### Belite Bio Logo icon format Download SVG (3.37 KB)

![Belite Bio Logo icon format Download SVG (3.37 KB)](/img/orig/BLTE-5f1084c9.svg)

## Belite Bio Logo large for dark backgrounds

### Belite Bio Logo large for dark backgrounds Download PNG (31.94 KB)

![Belite Bio Logo large for dark backgrounds Download PNG (31.94 KB)](/img/orig/BLTE_BIG.D-d18a4c6e.png)

### Belite Bio Logo large for dark backgrounds Download SVG (8.19 KB)

![Belite Bio Logo large for dark backgrounds Download SVG (8.19 KB)](/img/orig/BLTE_BIG.D-1bbe1bf1.svg)

## Belite Bio Logo icon format for dark backgrounds

### Belite Bio Logo icon format for dark backgrounds Download PNG (31.54 KB)

![Belite Bio Logo icon format for dark backgrounds Download PNG (31.54 KB)](/img/orig/BLTE.D-7265cfb8.png)

### Belite Bio Logo icon format for dark backgrounds Download SVG (3.34 KB)

![Belite Bio Logo icon format for dark backgrounds Download SVG (3.34 KB)](/img/orig/BLTE.D-083bbad8.svg)

## About Belite Bio

Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that is in phase 3 clinical trial. The company is also developing LBS-009, an anti-retinol binding protein 4 oral therapy targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, which is in the preclinical development phase. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.

1. Website domain: belitebio.com
2. Employees: 12
3. Marketcap: $0.72 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
